Charles Schwab Investment Management Inc Uni Qure N.V. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 235,490 shares of QURE stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235,490
Previous 222,389
5.89%
Holding current value
$1.05 Million
Previous $1.51 Million
18.67%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding QURE
# of Institutions
148Shares Held
34.1MCall Options Held
1.07MPut Options Held
603K-
Vestal Point Capital, LP New York, NY4.73MShares$21.2 Million2.03% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.09MShares$13.8 Million1.03% of portfolio
-
683 Capital Management, LLC New York, NY1.98MShares$8.85 Million0.88% of portfolio
-
Black Rock Inc. New York, NY1.86MShares$8.34 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.52MShares$6.8 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $209M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...